Search Results 151-160 of 19122 for prostate cancer
... prostate cancer. Exploratory objectives include chronic/late toxicity, among others. Late toxicity rates in the current study should besimilar to what is ...
Find out about diagnosis and treatment of this cancer that has spread to the lymph nodes or other parts of the body.
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic ...
Dr. Oliver Sartor, a medical oncologist at Mayo. Clinic who is focused on prostate cancer, stresses the importance of screening for the disease with a.
Prostate cancer and prostatic diseases. 2020. Mar; 23(1):38-52. Theranostic principles utilize a molecular biomarker specific for a tumor target, initially ...
The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair defects in a population of men with metastatic Prostate Cancer (PC), and to use ...
... prostate cancer this year. While most forms of prostate cancer run an indolent course, metastatic castration-resistant prostate cancer (mCRPC) has an ...
Our data suggests PRSS3 activity changes the environment around prostate cancer cells — perhaps by freeing them from surrounding tissue — to promote malignancy ...
Prostate cancer is one of the most common types of cancer in men. Usually prostate cancer grows slowly and initially remains confined to the prostate gland ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.